Skip to main content
SpringerLink
Log in

Indikation zur radikalen Prostatektomie — Wann?

  • Kontroversen in der Uro-Onkologie
  • Published:
Der Urologe B

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Albertsen P, Fryback D, Storer B, Kolon T, Fine J (1995) Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274: 626–631

    Article  CAS  PubMed  Google Scholar 

  2. Aus G, Hugosson J, Norlen L (1995) Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol 154: 460–465

    Article  CAS  PubMed  Google Scholar 

  3. Boxer RJ, Kaufman JJ, Goodwin WE (1977) Radical prostatectomy for carcinoma of the prostate: 1951–1976. A review of 329 patients. J Urol 117: 208–213

    CAS  PubMed  Google Scholar 

  4. Carter HB, Sauvageot J, Walsh PC, Epstein JI (1997) Prospective evaluation of men with stage T1c adenocarcinoma of the prostate. J Urol 157: 2206–2209

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Catalona WJ, Smith DS (1994) 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 152: 1837–1842

    CAS  PubMed  Google Scholar 

  6. Catalona WJ, Stein AJ, Fair WR (1982) Grading errors in prostatic needle biopsies: relation to the accuracy of tumor grade in predicting pelvic lymph node metastases. J Urol 127: 919–922

    CAS  PubMed  Google Scholar 

  7. Corral DA, Bahnson RR (1994) Survival of men with clinically localized prostate cancer detected in the eight decade of life. J Urol 151: 1326–1329

    CAS  PubMed  Google Scholar 

  8. Davidson PJT, Van den Ouden D, Schroeder FH (1996) Radical prostatectomy: prospective assessment of mortality and morbidity. Eur Urol 29: 168–173

    CAS  PubMed  Google Scholar 

  9. Flanigan RC, McKay TC, Olson M, Shankey TV, Pyle J, Waters WB (1996) Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. Urology 48: 428–432

    Article  CAS  PubMed  Google Scholar 

  10. Frohmüller H, Theiß M, Wirth M, Hofmockel G (1995) 15-Jahres Ergebnisse der radikalen Prostatektomie. Urologe [A] 34: 225–230

    Google Scholar 

  11. Frohmüller H, Theiss M, Wirth MP (1991) Radical prostatectomy for carcinoma of the prostate: long-term follow up of 115 patients. Eur Urol 19: 279–283

    PubMed  Google Scholar 

  12. Gaker DL, Gaker LB, Steward JF, Gillenwater JY (1996) Radical prostatectomy with preservation of urinary continence. J Urol 156: 445–449

    Article  CAS  PubMed  Google Scholar 

  13. Geary ES, Dendinger TE, Freiha FS, Stamey TA (1995) Nerve sparing radical prostatectomy: a different view. J Urol 154: 145–149

    Article  CAS  PubMed  Google Scholar 

  14. Hammerer P, Hubner D, Gonnermann D, Huland H (1995) Peri-und postoperative Komplikationen der pelvinen Lymphadenektomie nach radikaler Prostatektomie an 320 konsekutiven Patienten. Urologe [A] 34: 334–342

    CAS  Google Scholar 

  15. Humphrey PA, Keetch DW, Smith DS, Shepherd DL, Catalona WJ (1996) Prospective characterization of pathological features of prostatic carcinoma detected via serum prostate specific antigen based screening. J Urol 155: 816–820

    Article  CAS  PubMed  Google Scholar 

  16. Johansson JE, Adami HO, Andersson SO, Bergström R, Holmberg L, Krusemo UB (1992) High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA 267: 2191–2196

    Article  CAS  PubMed  Google Scholar 

  17. Kleinschmidt K, Vieweg J, Gottfried HW, Miller K, Hautmann R (1991) Intra-und postoperative Morbidität der radikalen Prostatektomie. Urologe [A] 30: 387–393

    CAS  Google Scholar 

  18. Leach GE, Cooper F, Kagan R, Snyder R, Forsythe A (1982) Radiotherapy for prostatic carcinoma: post-irradiation prostatic biopsy and recurrence patterns with long-term followup. J Urol 128: 505–509

    CAS  PubMed  Google Scholar 

  19. Leandri P, Rossignol G, Gautier JR, Ramon J (1992) Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. J Urol 147: 883–887

    CAS  PubMed  Google Scholar 

  20. Lerner SE, Blute ML, Zincke H (1995) Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity. J Urol 154: 1447–1452

    Article  CAS  PubMed  Google Scholar 

  21. Manseck A, Wirth M (1997) Clinical value of prostate-specific antigen-detected prostate carcinoma (Stage T1c). Onkologie 20: 306–309

    Article  Google Scholar 

  22. Middleton RG, Thompson MS, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, Miller HC, Oesterling JE, Mesnick MI, Smalley SR, Wasson JH (1995) Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. J Urol 154: 2144–2148

    Article  CAS  PubMed  Google Scholar 

  23. Morgan WM, Bergstralh EJ, Zincke H (1993) Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer. Urology 41: 113–120

    Article  CAS  PubMed  Google Scholar 

  24. Murphy MP, Mettlin C, Menck H, Winchester DP, Davidson AM (1994) National patterns of prostate cancer treatment of radical prostatectomy results of a survey by the American College of Surgeons Commission on Cancer. J Urol 152: 1817–1819

    CAS  PubMed  Google Scholar 

  25. NCI (1997) SEER Cancer statistics review 1973–1994. National Cancer Institute

  26. Oesterling JE, Suman VJ, Zincke H, Bostwick DG (1993) PSA-detected (clinical stage T1c or B0) prostate cancer. Urol Clin North Am 20: 687–693

    CAS  PubMed  Google Scholar 

  27. Ohori M, Goad JR, Wheeler TM, Eastham JA, Thompson TC, Scardino PT (1994) Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 152: 1843–1849

    CAS  PubMed  Google Scholar 

  28. Partin AW, Borland RN, Epstein JI, Brendler CB (1993) Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration. J Urol 150: 142–146

    CAS  PubMed  Google Scholar 

  29. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT, Pearson JD (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional up-date. JAMA 277: 1445–1451

    Article  CAS  PubMed  Google Scholar 

  30. Partin AW, Lee BR, Carmichael M, Walsh PC, Epstein JL (1994) Radical prostatectomy for high grade disease: a reevaluation 1994. J Urol 151: 1583–1586

    CAS  PubMed  Google Scholar 

  31. Paulson DF, Lin GH, Hinshaw W, Stephani S (1982) Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol 128: 502–504

    CAS  PubMed  Google Scholar 

  32. Paulson DF, Moul JW, Walther PJ (1990) Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long term results. J Urol 144: 1180–1184

    CAS  PubMed  Google Scholar 

  33. Rosen MA, Goldstone L, Lapin S, Wheeler T, Scardino P (1992) Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. J Urol 148: 331–337

    CAS  PubMed  Google Scholar 

  34. Rossetti SR, Terrone C (1996) Quality of life in prostate cancer patients. Eur Urol 30 [Suppl 1]: 44–48

  35. Rossignol G, Leandri P, Ramon J, Gautier JR (1992) Radical prostatectomy in the management of stage A carcinoma of the prostate. Eur Urol 21: 269–273

    CAS  PubMed  Google Scholar 

  36. Smith DS, Catalona WJ (1994) The nature of prostate cancer detected through prostate specific antigen-based screening. J Urol 152: 1732

    CAS  PubMed  Google Scholar 

  37. Steiner M, Morton RA, Walsh PC (1991) Impact of anatomical radical prostatectomy on urinary continence. J Urol 145: 512–514

    CAS  PubMed  Google Scholar 

  38. Steiner MS (1995) Current results and patient selection for nerve sparing radical retropubic prostatectomy. Semin Urol Oncol 13: 204–214

    CAS  PubMed  Google Scholar 

  39. Stormont TJ, Farrow GM, Myers RP, Blute ML, Zincke H, Wilson TM, Oesterling JE (1993) Clinical stage BO or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration. Urology 41: 3–8

    Article  CAS  PubMed  Google Scholar 

  40. Syndikus I, Pickles T, Kostashuk E, Sullivan LD (1996) Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control. J Urol 155: 1983–1986

    Article  CAS  PubMed  Google Scholar 

  41. Thompson JM, Paradelo JC, Crawford ED, Coltman CA, Blumenstein B (1994) An opportunity to determine optimal treatment of pT3 prostate cancer: the window may be closing. Urology 44: 804–811

    Article  CAS  PubMed  Google Scholar 

  42. Van den Ouden D, Davidson PJ, Hop W, Schroder FH (1994) Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer. J Urol 151: 646–651

    PubMed  Google Scholar 

  43. Walsh PC, Partin AW, Epstein JI (1994) Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 152: 1831–1836

    CAS  PubMed  Google Scholar 

  44. Whittemore A (1994) Prostate cancer: trends in cancer incidence and mortality. Cancer Surv 19/20: 309

    Google Scholar 

  45. Zagars GK, Von Eschenbach AC, Johnson DE, Oswald MJ (1987) Stage C adenocarcinoma of the prostate: an analysis of 551 patients treated with external beam radiation. Cancer 60: 1489–1499

    Article  CAS  PubMed  Google Scholar 

  46. Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM (1994) Longterm (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 152: 1850–1857

    CAS  PubMed  Google Scholar 

  47. Zincke H, Utz DC, Taylor WF (1986) Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression. J Urol 135: 1199–1205

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Urologie, Medizinische Fakultät „Carl Gustav Cams“, TU Dresden, Fetscherstraße 74, D-01307, Dresden

    M. Wirth, S. E. Froschermaier & A. Manseck

Authors
  1. M. Wirth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. E. Froschermaier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Manseck
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wirth, M., Froschermaier, S.E. & Manseck, A. Indikation zur radikalen Prostatektomie — Wann?. Der Urologe B 38, S65–S69 (1998). https://doi.org/10.1007/s001310050378

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001310050378

Search

Navigation